TLCR Reading Tools
How to cite item
Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{108697}, author = {Zhang, H., Wu, Z., Lu, T., Zhang, H., Li, J., Zhang, D., Yu, S., Guo, X., Feng, X., Liu, J., Shi, Y., Gao, X., Liu, X., Chen, M., Zhao, J., Zhong, W., Hu, Y., Xu, Y., Wang, M.}, title = {Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study}, journal = {Translational Lung Cancer Research}, volume = {14}, number = {11}, year = {2025}, url = {https://tlcr.amegroups.org/article/view/108697} }